AstraZeneca’s coronavirus vaccine triggers ‘strong immune response’: study
Share article:
Share article:

AstraZeneca’s coronavirus vaccine triggers ‘strong immune response’: study

© Jonas D'Hollander/Belga

The coronavirus vaccine being jointly developed by AstraZeneca and researchers at Oxford University provides “a strong immune response,” a new study shows.

A team of researchers at Bristol University examined the vaccine’s response upon entering the human body and said that it accurately follows the necessary genetic instructions.

“We are able to confirm that the genetic instructions underpinning this vaccine, which is being developed fast as safely as possible, are correctly followed when they get into a human cell,” lead researcher David Matthews told British media.

Related News:


Matthews said that the study was the first one so far who had been able to provide clear answers and show that the candidate vaccine “is doing everything we expected,” hailing the results as “good news in our fight against the illness.”

Sarah Gilbert, a leading researcher involved in the clinical trials, said that the study showed that the vaccine candidate was able to reproduce large amounts of the “spike protein” characteristic of the coronavirus with “great accuracy.”

“This goes a long way to explaining the success of the vaccine in inducing a strong immune response,” she added, since the vaccine aimed to train the body to recognise and fight the virus upon real contamination.

The findings of the Bristol University study have not yet been peer-reviewed and have been shared prior to publication in a scientific journal, the researchers said.

The candidate vaccine is currently going through final, Phase-3 clinical trials and millions of doses have already been secured by the EU and other national governments.

Through the EU’s deal with pharma giant AstraZeneca —one of three clinched by the bloc— Belgium is set to receive some 3 million doses of the candidate shot, pending its regulatory approval, which officials have said could begin being delivered in the spring.

In early September, the vaccine trials were temporarily halted after a UK participant developed a “serious side effect,” but were resumed after evaluation.

Gabriela Galindo
The Brussels Times

Latest news

Thousands protest against the Covid health pass in France
Demonstrations against the health pass and other measures aimed at preventing the spread of the novel Coronavirus (COVID-19) mobilised tens of ...
Record-breaking 770-metre highline installed in Freÿr, Beglium
A 770-metre long highline was installed at an altitude of 70 metres at the Freÿr Rocks on Saturday, setting a new Belgian record, according to ...
Will Brussels bounce back?
The lockdowns have tested the city and forced it to confront key questions about its future. Derek Blyth looks back at an extraordinary moment in our ...
Huge cannabis farm discovered inside closed down Chinese restaurant near Charleroi
A cannabis plantation with several hundred mature plants was dismantled on Friday evening in a former Chinese restaurant on Chaussée de Bruxelles ...
Citizen founded wind turbine project launched in Liège region
A citizen founded wind turbine project was inaugurated in the Liège Region on Saturday by Walloon Energy Minister Philippe Henry (Ecolo) together ...
Five questions to philosopher Philippe Van Parijs on Leopold II and embarrassment in Brussels’ public space
The worldwide explosion of the Black Lives Matter movement in the aftermath of the death of George Floyd, combined with the 60th anniversary of the ...
Belgium to invest in sustainable heating in 2022
The federal government will set aside about one million euros in its 2022 budget for a social tariff for sustainable heating, Federal Energy Minister ...
Anti-vaxxers demonstrate against Covid Safe Ticket in Brussels
Hundreds of supporters of the anti-vaxx movement gathered on Saturday outside the headquarters of the Pfizer pharmaceutical company to protest ...
Belgium’s investment funds total 260 billion euros in assets
Belgium’s funds industry grew by 5.3% (13 billion euros) in the second quarter of this year, bringing investment funds available to the public to ...
Brussels to Luxembourg by train in two hours soon possible
The fastest train ride between Brussels and Luxembourg currently takes almost three hours, but that could be slashed to about two hours thanks to the ...
Daily Covid infections up by almost 30% in Belgium
Between 6 and 12 October, an average of 2,438 people were infected with the Covid-19 virus every day, according to figures from the Sciensano public ...
Over 80,000 companies in Belgium non-compliant with anti-money laundering meassures
Over 80,000 companies and non-profits in Belgium are still not compliant with the Ultimate Business Owner (UBO) register, which is required of them ...